The antibacterial and antifungal activity of a series of products, in which the 1,5-dimethyl-4-(cyano-NNO-azoxy)pyrazol-3-yl and 1,3-dimethyl-4-(cyano-NNO-azoxy)pyrazol-5-yl moieties were linked to pyridine, pyrazole, isoxazole, thiophene and the furan ring, were examined. No molecule displayed activity against the Gram-negative bacteria tested. Conversely, some compounds displayed activity against two Staphylococcus aureus strains, including the methicillin resistant strain. All compounds displayed interesting antifungal activity, the most active compound of the series being the thiophene derivative 7a. This compound's activity against Candida krusei and Candida glabrata (MIC = 0.25 and 0.5 lg/mL, respectively), two fungal species resistant to azoles, is noteworthy. The presence of the cyano function appeared essential for activity.
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The azoxycyanide functional group (-N(O)@N-CN) was originally discovered in the antibiotic calvatic acid (4-carboxyphenyl-ONNazoxycyanide, 4-(cyano-NNO-azoxy)benzoic acid), which was first isolated from a culture broth of Calvatia lilacina (BERK.) Henn. P., 1 then from cultures of Calvatia craniformis (SHW.) Fr., 2 and Lycoperdon pyriforme.
Calvatic acid
Calvatic acid displays significant antifungal and antibacterial activity, as well as in vitro and in vivo antitumor activity. 2, 4 It also has activity against a number of strains of Helicobacter pylori, including metronidazole resistent ones. 5 The antibiotic also shows a range of specific biological functions; among these are inhibition of [ 3 H] colchicine binding to soluble tubulin, inhibition of human placenta glutathione transferase, as well as of ornithine decarboxylase. [6] [7] [8] The structure of Calvatic acid has been used as a starting point in several other studies; in particular, the azoxycyanide function has been inserted in a variety of aryl and heteroaryl vectors.
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The resulting compounds displayed the general activities of the lead, but with a range of potency and specificity. They are superior antifungal agents compared to the parent compound. These derivatives have also been examined as potential agricultural fungicides. 14 The results are reported of a study of the antibacterial and antifungal activity of a series of products in which the 1,5-dimethyl-4-(cyano-NNO-azoxy)pyrazol-3-yl and 1,3-dimethyl-4-(cyano-NNO-azoxy)pyrazol-5-yl moieties R 3 and R 5 (Table 1) were linked to pyridine, pyrazole, isoxazole, thiophene and furan ring. In order to elucidate the significance of the cyano function on activity, the carbamoyl 10 and tosyl 11 analogues of 7a, the most active compound of the series, were also examined. Scheme 1 outlines the preparation of the final azoxycyano derivatives. The starting materials were the 1-methyl-4-nitrosopyrazoles derivatives 1-9, bearing methyl and heteroaryl substituents at 3-and 5-positions. These products were transformed into the final compounds by regiospecific synthesis, as described by Fruttero et al. 15 and later modified by Wood et al, 13 with the exception of the oxidative-breakdown-susceptible furan derivative 9a, for which the procedure was partially modified. Nitrosoderivatives were treated in dry CH 2 Cl 2 with a mixture of cyanamide (NH 2 CN) and (diacetoxy)iodobenzene (IBA), giving the expected final products, probably through the intermediate formation of cyanonitrene. All products showed the fragment ions [MÀ40] + in their mass spectra, due to loss of CN 2 , typical of this class of compounds. 16 Compound 10 was easily obtained by bubbling HCl through a THF/H 2 O solution of 7a, following the general procedure described elsewhere, 12 while compound 11 was synthesized by action of the nitrene precursor N-tosyliminoiodinane, prepared by a known procedure, 17 on 7 dissolved in acetonitrile containing activated 4 Å molecular sieves (MS) and CuCl (Scheme 2).
0960-894X/$ -see front matter Ó 2011 Elsevier Ltd. All rights reserved. doi:10.1016/j.bmcl.2011.03.101 Table 1 In vitro activities of the designed compounds (MIC, The first seven products were tested against two strains of Staphylococcus aureus, one resistant (MR) and the other susceptible (MS) to methicillin, three species of Gram-negative bacteria, Proteus mirabilis, Escherichia coli and Pseudomonas aeruginosa, six fungal species belonging to Candida spp., and Cryptococcus neoformans var. neoformans. Because both yeasts and S. aureus can be normal microbiota of human mucosa and skin, the yeasts and the two S. aureus isolates used in this study were collected from human sterile clinical specimens (blood and cerebrospinal fluid), Gram-negative bacteria were isolated from urine having a colony forming unit (CFU) count above the cutoff of >10 5 CFU. Antimicrobial assays were performed with a microdilution broth method, following standard protocols for in vitro antibacterial and antifungal susceptibility testing. 21, 22 The results are in Table 1 23 .
The antimicrobial data showed that none of the molecules displayed activity against the Gram negative bacteria tested. Conversely, except for 1a and 6a, they displayed some activity against both S. aureus strains, including the MR strain, against 
Table 2
Comparison of in vitro activities of the designed compounds with that of the widely used systemic antifungal drugs (MIC, lg/mL) From this standpoint, the lowest MIC values were displayed by derivatives 4a, 5a, and 7a, respectively bearing the 3-methyl-5-oxazolyl, 5-methyl-3-oxazolyl, and thiophen-2-yl substituent at the 3-position of the pyrazolylazoxycyanide scaffold R 3 . As far as antifungal activity is concerned, the most active product was 7a: this is a potent antifungal product active against almost all the species tested. Candida parapsilosis and Candida tropicalis isolates had higher MIC values than those of the other yeasts tested. The activity against Candida krusei, which displays intrinsic fluconazole resistance, and against Candida glabrata, which has acquired resistance to azoles, are of note ( Table 2) . 24 When the thienyl substituent was moved to position 5 of the pyrazole ring, to give compound 8a, the level of activity remained high, MIC values being within ±2 log 2 dilutions. Compound 8a was particularly active against the strains of Cryptococcus neoformans, which was susceptible to all the pyrazolylazoxycyanide derivatives tested. When in 7a the furan moiety was substituted for the thiophene, giving compound 9a, activity against all the species under study remained high, declining only for the strains of C. tropicalis. The presence of the azoxycyano function in these products appeared to be essential to their activity: the cyano group was substituted in 7a with two other electron-withdrawing moieties, the carbamoyl and the tosyl moiety respectively, giving products 10 and 11, which were inactive.
In conclusion, interesting pyrazole derivatives displaying antifungal activity were developed. In particular, compounds 7a, 8a, 9a deserve further structural modulation, owing to their potent action against C. krusei and C. glabrata, two fungal species resistant to azoles.
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